The Recall Desk
Agency classClass IOur severity:CriticalFDA (Drugs)·D-0332-2026·Announced 2026-02-11

Rheumacare capsules recalled after the product was found to contain lead

Handelnine Global is recalling four bottles of Rheumacare capsules after the product was found to contain lead.

The agency’s classification

FDA (Drugs): Class I

Class I is a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.

This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work

What this means for you

Our assessment, not the agency’s: severity 5/5 (Critical).

Highest-severity recall. The hazard can cause serious injury or death. Stop using the product now and follow the agency's instructions.

Our severity reasoning: Scored 5 because the FDA has classified this action as Class I, which the rubric maps directly to Critical.

Plain-English summary

Rheumacare capsules, in 30-count bottles, manufactured in India by Virgo UAP Pharma Pvt. Ltd. of Ahmedabad, under UPC 8 904218 700313, are being recalled by Handelnine Global LLC.

The reason given in the enforcement record is CGMP deviations: the product was found to contain lead.

The record lists 4 bottles of 30 capsules each, from lot CAM040, expiry 06/30/2029, and lot CAL079-N, expiry 09/30/2028. The record states the product was distributed to one customer in New York. The FDA has classified the action as Class I, its most serious category.

Consumers who have this product should stop taking it and should follow the seller's return instructions.

The recalled product

Product
Rheumacare capsules, 30 count bottle, Mfg in India by: Virgo UAP Pharma Pvt. Ltd., Ahmedabad, India UPC 8 904218 700313

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (3)

  • Lot: CAM040
  • Exp. 06/30/2029 Lot: CAL079-N
  • Exp. 09/30/2028

Distribution

Distributed in 1 state:

Similar recalls